Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Buyse

Showing results (41-50 of 227) with videos related to

Pageof 23
Sort By:
Expert Review of Anticancer Therapy|November 6, 2003
Progress in the medical treatment of advanced colorectal cancerElizabeth Fabre-Guillevin, Pascal Piedbois, Marc Buyse
Annals of Translational Medicine|July 20, 2018
The search for surrogate endpoints for immunotherapy trialsMarc Buyse, Tomasz Burzykowski, Everardo D Saad
JAMA Oncology|November 29, 2016
Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open QuestionTomasz Burzykowski, Everardo D Saad, Marc Buyse
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trialsEverardo D Saad, Artur Katz, Marc Buyse
Statistical Methods in Medical Research|February 21, 2008
Individual- and trial-level surrogacy in colorectal cancerMarc Buyse, Tomasz Burzykowski, Stefan Michiels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Survival is not a good outcome for randomized trials with effective subsequent therapiesMarc Buyse, Daniel J Sargent, Everardo D Saad
Current Opinion in Oncology|January 1, 2005
Challenges in breast cancer clinical trial design in the postgenomic eraSherene Loi, Marc Buyse, Christos Sotiriou, et al.
Statistical Methods in Medical Research|June 17, 2004
A perspective on surrogate endpoints in controlled clinical trialsGeert Molenberghs, Tomasz Burzykowski, Ariel Alonso, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 9, 2003
Is FOB screening really the answer for lowering mortality in colorectal cancer?Philippe Autier, Peter Boyle, Marc Buyse, et al.
Statistics in Medicine|January 30, 2015
Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkersLili Zhao, Dai Feng, Brian Neelon, et al.
Pageof 23

Showing results (41-50 of 227) with videos related to

Sort By:
Pageof 23
Expert Review of Anticancer Therapy|November 6, 2003
Progress in the medical treatment of advanced colorectal cancerElizabeth Fabre-Guillevin, Pascal Piedbois, Marc Buyse
Annals of Translational Medicine|July 20, 2018
The search for surrogate endpoints for immunotherapy trialsMarc Buyse, Tomasz Burzykowski, Everardo D Saad
JAMA Oncology|November 29, 2016
Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open QuestionTomasz Burzykowski, Everardo D Saad, Marc Buyse
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trialsEverardo D Saad, Artur Katz, Marc Buyse
Statistical Methods in Medical Research|February 21, 2008
Individual- and trial-level surrogacy in colorectal cancerMarc Buyse, Tomasz Burzykowski, Stefan Michiels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Survival is not a good outcome for randomized trials with effective subsequent therapiesMarc Buyse, Daniel J Sargent, Everardo D Saad
Current Opinion in Oncology|January 1, 2005
Challenges in breast cancer clinical trial design in the postgenomic eraSherene Loi, Marc Buyse, Christos Sotiriou, et al.
Statistical Methods in Medical Research|June 17, 2004
A perspective on surrogate endpoints in controlled clinical trialsGeert Molenberghs, Tomasz Burzykowski, Ariel Alonso, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 9, 2003
Is FOB screening really the answer for lowering mortality in colorectal cancer?Philippe Autier, Peter Boyle, Marc Buyse, et al.
Statistics in Medicine|January 30, 2015
Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkersLili Zhao, Dai Feng, Brian Neelon, et al.
Pageof 23